Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC’s ‘Awesome’ Suit Against Shire Targets Citizen Petitions

Executive Summary

46 filings with FDA were intended to block generic competition, FTC says in its first-ever suit over citizen petitions; role of consultants highlighted.

Advertisement

Related Content

FTC 'Ready' To Go After Abusive Citizen Petitions; Allergan Wants 'Substantive' FDA Responses
FTC 'Ready' To Go After Abusive Citizen Petitions; Allergan Wants 'Substantive' FDA Responses
Shire's Citizen Petitions Too Old For FTC Action; Door Left Open For Amended Suit
Will FTC Shakeup Impact Pharma?
Allergan Loses Another Battle, But War To Block Restasis Generics Continues
Allergan Loses Another Battle, But War To Block Restasis Generics Continues
Antibiotic Indications: Definition Of “Significant” Remains In FDA’s Hands After Vancocin Ruling
Vancocin Generics Launch As FDA Finds ViroPharma’s Label Fails “Significant New Use” Test
Generic Vancocin Gets Cmte. Endorsement, But So Do New Brand Products
ViroPharma Sets Legal Argument Against FDA Decision On Generic Vancocin

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS120004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel